The level of circRIP2 in bladder cancer patients is correlated with clinical prognosis, and chemokine (C-C motif) ligand 2 (CCL2) is differentially expressed in circRIP2 overexpressed cells [75]. This evidence concerns the gene CCL2 and urinary bladder cancer.